Cite

HARVARD Citation

    Smits, M. et al. (2016). GLP-1–Based Therapies Have No Microvascular Effects in Type 2 Diabetes Mellitus. Arteriosclerosis, thrombosis, and vascular biology. 36 (10), p. . [Online]. 
  
Back to record